PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'RayBiotech Guangzhou Co., Ltd., 79 Ruihe Road, Huangpu District, Guangzhou, Guangdong 510535, China; Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, China.\', \'Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.\', \'RayBiotech Life Inc., Peachtree Corners, GA 30092, USA.\', \'RayBiotech Guangzhou Co., Ltd., 79 Ruihe Road, Huangpu District, Guangzhou, Guangdong 510535, China; RayBiotech Life Inc., Peachtree Corners, GA 30092, USA.\', \'Department of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, China; National Engineering Research Center for Tissue Restoration and Reconstruction, 382 Outer Ring East Road, Guangzhou Higher Education Mega Centre, Panyu District, Guangzhou 510006, China; Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, 382 Outer Ring East Road, Guangzhou Higher Education Mega Centre, Panyu District, Guangzhou 510006, China. Electronic address: chenxf@scut.edu.cn.\', \'RayBiotech Guangzhou Co., Ltd., 79 Ruihe Road, Huangpu District, Guangzhou, Guangdong 510535, China; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China; RayBiotech Life Inc., Peachtree Corners, GA 30092, USA; South China Biochip Research Center, 79 Ruihe Road, Huangpu District, Guangzhou 510535, China. Electronic address: rhuang@raybiotech.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0022-1759(22)00031-X10.1016/j.jim.2022.113244
?:doi
?:hasPublicationType
?:journal
  • Journal of immunological methods
is ?:pmid of
?:pmid
?:pmid
  • 35218866
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.289
?:rankingScore_hIndex
  • 119
is ?:relation_isRelatedTo_publication of
?:title
  • The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35218866>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35218866>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all